Suchergebnisse - (Subject:"ritonavir")

PubPharm (1.798)

91

Characterization of HIV-1 drug resistance among patients with failure of second-line combined antiretroviral therapy in central Ethiopia

enthalten in: HIV medicine | 2022

von Tufa, T. | Fuchs, A. | Orth, H. | +11

92

What have we learned from the first to the second wave of COVID-19 pandemic? An international survey from the ESCMID Study Group for Infection in the Elderly (ESGIE) group

enthalten in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology | 2022

von Tiseo, G. | Yahav, D. | Paul, M. | +5

93

Protease inhibitor-based antiretroviral therapy in pregnancy : effects on hormones, placenta, and decidua

enthalten in: The lancet. HIV | 2022

von Dunk, C. | Serghides, L.

94

Physiologically Based Pharmacokinetic Modeling of 3 HIV Drugs in Combination and the Role of Lymphatic System after Subcutaneous Dosing. Part 1 : Model for the Free-Drug Mixture

enthalten in: Journal of pharmaceutical sciences | 2022

von Perazzolo, S. | Shireman, L. | Shen, D. | +1

95

Brief Report : No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297)

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2022

von Shaffer, D. | Kumwenda, J. | Chen, H. | +12

96

Lopinavir/Ritonavir : A Review of Analytical Methodologies for the Drug Substances, Pharmaceutical Formulations and Biological Matrices

enthalten in: Critical reviews in analytical chemistry | 2022

von Velozo, C. | Cabral, L. | Pinto, E. | +1

97

Molnupiravir in COVID-19 : A Scoping Review

enthalten in: Current drug research reviews | 2022

von Kaore, S. | Atal, S.

98

Use of combined treatment of 3rd-generation cephalosporin, azithromycin and antiviral agents on moderate SARs-CoV-2 patients in South Korea : A retrospective cohort study

enthalten in: PloS one | 2022

von Hong, W. | Park, Y. | Kim, B. | +8

99

Darunavir-cobicistat versus lopinavir-ritonavir in the treatment of COVID-19 infection (DOLCI) : A multicenter observational study

enthalten in: PloS one | 2022

von Elmekaty, E. | Alibrahim, R. | Hassanin, R. | +8

100

Comparison of demographic and clinical characteristics of hospitalized COVID-19 patients with severe/critical illness in the first wave versus the second wave

enthalten in: Journal of medical virology | 2022

von Sargin Altunok, E. | Satici, C. | Dinc, V. | +7